Brief: Diasorin Receives 510(K) Authorization From U.S. FDA For Liaison Plex Gram-Positive Blood Culture Assay
09/06/2025 09:45
June 9 (Reuters) - DiaSorin SpA DIAS.MI: RECEIVES 510(K) AUTHORIZATION FROM U.S. FDA FOR LIAISON PLEX GRAM-POSITIVE BLOOD CULTURE ASSAY AUTHORIZATION COMPLETES PORTFOLIO OF PANELS FOR DIAGNOSIS OF BLOOD INFECTIONS ON LIAISON PLEX Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21